Building companies, accelerating development.
Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising life science investment opportunities.
Investor Login
Sign in to our secure investor area to receive personalized updates and information. Login now »
Recent Additions
- Zelos Therapeutics Reaches Agreement with the FDA and EMEA for a Registration Study of ZT-031 for the Treatment of Osteo
- Zelos Therapeutics, Inc. has reached agreements with the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMEA)... Read more
- Insception Biosciences Begins Human Clinical Trials of Stem Cell Treatment That Could Replace Bone Marrow Transplants
- Toronto, ON (February 6, 2008) Insception Biosciences Inc., a privately-held company that develops stem cell treatments, announced today it has... Read more
